The Vaishali Pharma IPO GMP strength score is 8 out of 10, which the dashboard rates as Strong. The Vaishali Pharma IPO NII/HNI category is reserved for 47.37% of the offer. The Vaishali Pharma IPO Retail (RII) category is reserved for 47.37% of the offer. Live subscription numbers for the Vaishali Pharma IPO are not yet available, and amounts are calculated at the upper price band of ₹72.
Subscription data for Vaishali Pharma IPO is not available right now. Numbers are updated here during the bidding window.
In Vaishali Pharma IPO, retail investors can apply for a minimum of 1 lot(s) (₹₹115,200); HNI/sNII minimum 2 lots (₹₹230,400).
Shares offered by category — Retail 936,000 (47%) shares.
Subscription is shares bid for divided by shares offered in that category. If 10 lakh shares are offered and 50 lakh are bid for, the category is subscribed 5 times. Final numbers are confirmed after the bidding closes.
The NII category covers investors applying for shares outside the retail investor category, while HNI commonly refers to high-value investors within the NII category. Understanding the Vaishali Pharma IPO's NII and HNI subscription levels helps investors assess demand for the Vaishali Pharma IPO and overall investor interest.
GMP and IPO data are unofficial and for information only — not investment advice.
Read the full disclaimer.
